Advances in drug nanodelivery systems for the treatment of intracellular bacterial infections

被引：0
|
作者：
Ju X. [1 ]
Song W. [1 ]
Zhou C. [1 ]
Shen Q. [1 ]
Liao Y. [1 ]
Gong J. [1 ]
Chu L. [1 ]
机构：
[1] School of Chemical Engineering, Sichuan University, Sichuan, Chengdu
来源：
Huagong Xuebao/CIESC Journal | 2024年 / 75卷 / 04期
关键词：
antibacterial strategy; bacterial targeting; intracellular bacteria; nanocarriers;
D O I：
10.11949/0438-1157.20231326
中图分类号：
学科分类号：
摘要：
Intracellular bacteria can escape the body's immunity and grow and reproduce normally in the host cell, which are more difficult to remove than extracellular bacteria and can easily cause more serious infections. With traditional antibiotic treatment, the drugs cannot break through the host cell membrane barrier and can easily cause strong toxic side effects and multidrug resistance. Excellent nanocarriers have good biocompatibility and are easy to modify, which is expected to enhance membrane penetration and bacterial targeting of antibacterial drugs through the construction of nanodelivery systems, offering great potential and broad prospects in the treatment of intracellular bacterial infections. This paper introduces various nanoparticles that can be used to treat intracellular bacterial infections, summarizes the mechanisms and methods for enhancing the therapeutic effects of drug nanodelivery systems, and elaborates on the problems that still exist when using nano-drug delivery systems to treat intracellular bacterial infections, in order to provide inspiration for the construction of better drug delivery systems to treat intracellular bacterial infections. © 2024 Materials China. All rights reserved.
引用
收藏
页码：1153 / 1166
页数：13
相关论文
共 111 条
  • [1] Mak T W, Saunders M E., The Mmmune Response: Basic and Clinical Principles, (2005)
  • [2] Zou J, Shankar N., The opportunistic pathogen Enterococcus faecalis resists phagosome acidification and autophagy to promote intracellular survival in macrophages, Cellular Microbiology, 18, 6, pp. 831-843, (2016)
  • [3] Nejman D, Livyatan I, Fuks G, Et al., The human tumor microbiome is composed of tumor type-specific intracellular bacteria, Science, 368, 6494, pp. 973-980, (2020)
  • [4] Fu A K, Yao B Q, Dong T T, Et al., Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer, Cell, 185, 8, pp. 1356-1372, (2022)
  • [5] Galeano Nino J L, Wu H R, LaCourse K D, Et al., Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer, Nature, 611, pp. 810-817, (2022)
  • [6] LaCourse K D, Zepeda-Rivera M, Kempchinsky A G, Et al., The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota, Cell Reports, 41, 7, (2022)
  • [7] Subramaniam S, Joyce P, Thomas N, Et al., Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections, Advanced Drug Delivery Reviews, 177, (2021)
  • [8] Chen G Y, Roy I, Yang C H, Et al., Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy, Chemical Reviews, 116, 5, pp. 2826-2885, (2016)
  • [9] Huh A J, Kwon Y J, Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, Journal of Controlled Release, 156, 2, pp. 128-145, (2011)
  • [10] Tang L, Zhang A N, Zhang Z Y, Et al., Multifunctional inorganic nanomaterials for cancer photoimmunotherapy, Cancer Communications, 42, 2, pp. 141-163, (2022)
12345678910